Form 4: Twist Bioscience Executive Robert F. Werner Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Robert F. Werner, Chief Accounting Officer of Twist Bioscience, sold 1,448 shares of common stock on November 6, 2024, to cover tax obligations related to vesting Performance Stock Units.
Summary
- On November 6, 2024, Robert F. Werner, the Chief Accounting Officer of Twist Bioscience Corp, sold 1,448 shares of the company's common stock.
- The sale was executed at a price of $44.605 per share.
- This transaction was conducted to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain Performance Stock Units (PSUs).
- Following the transaction, Werner directly owns 45,620 shares of Twist Bioscience Corp.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover taxes is a normal occurrence and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of insider trading activity and are required by the SEC to provide transparency into the transactions of company insiders. This transaction appears to be a standard sale to cover tax obligations, which is a common practice.
Key Dates
| Date | Description |
|---|---|
| 11/06/2024 | Date of stock sale transaction. |
| 11/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.